iRNA-3typeA: Identifying Three Types of Modification at RNA’s Adenosine Sites

RNA modifications are additions of chemical groups to nucleotides or their local structural changes. Knowledge about the occurrence sites of these modifications is essential for in-depth understanding of the biological functions and mechanisms and for treating some genomic diseases as well. With the avalanche of RNA sequences generated in the post-genomic age, many computational methods have been proposed for identifying various types of RNA modifications one by one. However, so far no method whatsoever has been developed for simultaneously identifying several different types of RNA modifications. To address such a challenge, we developed a predictor called “iRNA-3typeA,” by which we can simultaneously identify the occurrence sites of the following three most frequently observed modifications in RNA: (1) N1-methyladenosine (m1A), (2) N6-methyladenosine (m6A), and (3) adenosine to inosine (A-to-I). It has been shown via rigorous cross-validations for the RNA sequences from Homo sapiens and Mus musculus transcriptomes that the success rates achieved by the powerful new predictor are quite high. For the convenience of broad experimental scientists, a user-friendly web server for iRNA-3typeA has been established at http://lin-group.cn/server/iRNA-3typeA/. It is anticipated that iRNA-3typeA may become a useful high throughput tool for genome analysis..

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Molecular Therapy: Nucleic Acids - 11(2018), C, Seite 468-474

Sprache:

Englisch

Beteiligte Personen:

Wei Chen [VerfasserIn]
Pengmian Feng [VerfasserIn]
Hui Yang [VerfasserIn]
Hui Ding [VerfasserIn]
Hao Lin [VerfasserIn]
Kuo-Chen Chou [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.sciencedirect.com [kostenfrei]
Journal toc [kostenfrei]

Themen:

Adenosine to inosine editing
Five-step rules
N1-methyladenosine
N6-methyladenosine
RNA modification
Therapeutics. Pharmacology
Web server

doi:

10.1016/j.omtn.2018.03.012

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ029908175